The global Rilpivirine market size was valued at US$ 1.12 billion in 2024 and is projected to reach US$ 1.56 billion by 2030, at a CAGR of 5.7% during the forecast period 2024-2030.
United States Rilpivirine market size was valued at US$ 567 million in 2024 and is projected to reach US$ 776 million by 2030, at a CAGR of 5.4% during the forecast period 2024-2030.
Rilpivirine is a non-nucleoside reverse transcriptase inhibitor used in combination with other antiretroviral agents for HIV treatment.
Growth supported by increasing use in single-tablet regimens and switch therapy. Development of long-acting injectable formulations expanding market potential. Rising adoption in resource-limited settings due to favorable safety profile.
Report Overview
This report provides a deep insight into the global Rilpivirine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Rilpivirine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Rilpivirine market in any manner.
Global Rilpivirine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Janssen Cilag International
- Gilead Sciences
- ViiV Healthcare
- Strides Pharma Science Limited
- Pharmacare Limited
- Aspen
Market Segmentation (by Type)
- Self-production API
- Outsourcing of API
Market Segmentation (by Application)
- Hospital
- Clinic
- Drug Center
- Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Rilpivirine Market
- Overview of the regional outlook of the Rilpivirine Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the
major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Rilpivirine
1.2 Key Market Segments
1.2.1 Rilpivirine Segment by Type
1.2.2 Rilpivirine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Rilpivirine Market Overview
2.1 Global Market Overview
2.1.1 Global Rilpivirine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Rilpivirine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Rilpivirine Market Competitive Landscape
3.1 Global Rilpivirine Sales by Manufacturers (2019-2024)
3.2 Global Rilpivirine Revenue Market Share by Manufacturers (2019-2024)
3.3 Rilpivirine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Rilpivirine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Rilpivirine Sales Sites, Area Served, Product Type
3.6 Rilpivirine Market Competitive Situation and Trends
3.6.1 Rilpivirine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Rilpivirine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Rilpivirine Industry Chain Analysis
4.1 Rilpivirine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Rilpivirine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Rilpivirine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Rilpivirine Sales Market Share by Type (2019-2024)
6.3 Global Rilpivirine Market Size Market Share by Type (2019-2024)
6.4 Global Rilpivirine Price by Type (2019-2024)
7 Rilpivirine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Rilpivirine Market Sales by Application (2019-2024)
7.3 Global Rilpivirine Market Size (M USD) by Application (2019-2024)
7.4 Global Rilpivirine Sales Growth Rate by Application (2019-2024)
8 Rilpivirine Market Segmentation by Region
8.1 Global Rilpivirine Sales by Region
8.1.1 Global Rilpivirine Sales by Region
8.1.2 Global Rilpivirine Sales Market Share by Region
8.2 North America
8.2.1 North America Rilpivirine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Rilpivirine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Rilpivirine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Rilpivirine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Rilpivirine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Janssen Cilag International
9.1.1 Janssen Cilag International Rilpivirine Basic Information
9.1.2 Janssen Cilag International Rilpivirine Product Overview
9.1.3 Janssen Cilag International Rilpivirine Product Market Performance
9.1.4 Janssen Cilag International Business Overview
9.1.5 Janssen Cilag International Rilpivirine SWOT Analysis
9.1.6 Janssen Cilag International Recent Developments
9.2 Gilead Sciences
9.2.1 Gilead Sciences Rilpivirine Basic Information
9.2.2 Gilead Sciences Rilpivirine Product Overview
9.2.3 Gilead Sciences Rilpivirine Product Market Performance
9.2.4 Gilead Sciences Business Overview
9.2.5 Gilead Sciences Rilpivirine SWOT Analysis
9.2.6 Gilead Sciences Recent Developments
9.3 ViiV Healthcare
9.3.1 ViiV Healthcare Rilpivirine Basic Information
9.3.2 ViiV Healthcare Rilpivirine Product Overview
9.3.3 ViiV Healthcare Rilpivirine Product Market Performance
9.3.4 ViiV Healthcare Rilpivirine SWOT Analysis
9.3.5 ViiV Healthcare Business Overview
9.3.6 ViiV Healthcare Recent Developments
9.4 Strides Pharma Science Limited
9.4.1 Strides Pharma Science Limited Rilpivirine Basic Information
9.4.2 Strides Pharma Science Limited Rilpivirine Product Overview
9.4.3 Strides Pharma Science Limited Rilpivirine Product Market Performance
9.4.4 Strides Pharma Science Limited Business Overview
9.4.5 Strides Pharma Science Limited Recent Developments
9.5 Pharmacare Limited
9.5.1 Pharmacare Limited Rilpivirine Basic Information
9.5.2 Pharmacare Limited Rilpivirine Product Overview
9.5.3 Pharmacare Limited Rilpivirine Product Market Performance
9.5.4 Pharmacare Limited Business Overview
9.5.5 Pharmacare Limited Recent Developments
9.6 Aspen
9.6.1 Aspen Rilpivirine Basic Information
9.6.2 Aspen Rilpivirine Product Overview
9.6.3 Aspen Rilpivirine Product Market Performance
9.6.4 Aspen Business Overview
9.6.5 Aspen Recent Developments
10 Rilpivirine Market Forecast by Region
10.1 Global Rilpivirine Market Size Forecast
10.2 Global Rilpivirine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Rilpivirine Market Size Forecast by Country
10.2.3 Asia Pacific Rilpivirine Market Size Forecast by Region
10.2.4 South America Rilpivirine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Rilpivirine by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Rilpivirine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Rilpivirine by Type (2025-2030)
11.1.2 Global Rilpivirine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Rilpivirine by Type (2025-2030)
11.2 Global Rilpivirine Market Forecast by Application (2025-2030)
11.2.1 Global Rilpivirine Sales (Kilotons) Forecast by Application
11.2.2 Global Rilpivirine Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Rilpivirine Market Size Comparison by Region (M USD)
Table 5. Global Rilpivirine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Rilpivirine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Rilpivirine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Rilpivirine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rilpivirine as of 2022)
Table 10. Global Market Rilpivirine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Rilpivirine Sales Sites and Area Served
Table 12. Manufacturers Rilpivirine Product Type
Table 13. Global Rilpivirine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Rilpivirine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Rilpivirine Market Challenges
Table 22. Global Rilpivirine Sales by Type (Kilotons)
Table 23. Global Rilpivirine Market Size by Type (M USD)
Table 24. Global Rilpivirine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Rilpivirine Sales Market Share by Type (2019-2024)
Table 26. Global Rilpivirine Market Size (M USD) by Type (2019-2024)
Table 27. Global Rilpivirine Market Size Share by Type (2019-2024)
Table 28. Global Rilpivirine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Rilpivirine Sales (Kilotons) by Application
Table 30. Global Rilpivirine Market Size by Application
Table 31. Global Rilpivirine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Rilpivirine Sales Market Share by Application (2019-2024)
Table 33. Global Rilpivirine Sales by Application (2019-2024) & (M USD)
Table 34. Global Rilpivirine Market Share by Application (2019-2024)
Table 35. Global Rilpivirine Sales Growth Rate by Application (2019-2024)
Table 36. Global Rilpivirine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Rilpivirine Sales Market Share by Region (2019-2024)
Table 38. North America Rilpivirine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Rilpivirine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Rilpivirine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Rilpivirine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Rilpivirine Sales by Region (2019-2024) & (Kilotons)
Table 43. Janssen Cilag International Rilpivirine Basic Information
Table 44. Janssen Cilag International Rilpivirine Product Overview
Table 45. Janssen Cilag International Rilpivirine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Janssen Cilag International Business Overview
Table 47. Janssen Cilag International Rilpivirine SWOT Analysis
Table 48. Janssen Cilag International Recent Developments
Table 49. Gilead Sciences Rilpivirine Basic Information
Table 50. Gilead Sciences Rilpivirine Product Overview
Table 51. Gilead Sciences Rilpivirine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Gilead Sciences Business Overview
Table 53. Gilead Sciences Rilpivirine SWOT Analysis
Table 54. Gilead Sciences Recent Developments
Table 55. ViiV Healthcare Rilpivirine Basic Information
Table 56. ViiV Healthcare Rilpivirine Product Overview
Table 57. ViiV Healthcare Rilpivirine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. ViiV Healthcare Rilpivirine SWOT Analysis
Table 59. ViiV Healthcare Business Overview
Table 60. ViiV Healthcare Recent Developments
Table 61. Strides Pharma Science Limited Rilpivirine Basic Information
Table 62. Strides Pharma Science Limited Rilpivirine Product Overview
Table 63. Strides Pharma Science Limited Rilpivirine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Strides Pharma Science Limited Business Overview
Table 65. Strides Pharma Science Limited Recent Developments
Table 66. Pharmacare Limited Rilpivirine Basic Information
Table 67. Pharmacare Limited Rilpivirine Product Overview
Table 68. Pharmacare Limited Rilpivirine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Pharmacare Limited Business Overview
Table 70. Pharmacare Limited Recent Developments
Table 71. Aspen Rilpivirine Basic Information
Table 72. Aspen Rilpivirine Product Overview
Table 73. Aspen Rilpivirine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Aspen Business Overview
Table 75. Aspen Recent Developments
Table 76. Global Rilpivirine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 77. Global Rilpivirine Market Size Forecast by Region (2025-2030) & (M USD)
Table 78. North America Rilpivirine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 79. North America Rilpivirine Market Size Forecast by Country (2025-2030) & (M USD)
Table 80. Europe Rilpivirine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 81. Europe Rilpivirine Market Size Forecast by Country (2025-2030) & (M USD)
Table 82. Asia Pacific Rilpivirine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 83. Asia Pacific Rilpivirine Market Size Forecast by Region (2025-2030) & (M USD)
Table 84. South America Rilpivirine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 85. South America Rilpivirine Market Size Forecast by Country (2025-2030) & (M USD)
Table 86. Middle East and Africa Rilpivirine Consumption Forecast by Country (2025-2030) & (Units)
Table 87. Middle East and Africa Rilpivirine Market Size Forecast by Country (2025-2030) & (M USD)
Table 88. Global Rilpivirine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 89. Global Rilpivirine Market Size Forecast by Type (2025-2030) & (M USD)
Table 90. Global Rilpivirine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 91. Global Rilpivirine Sales (Kilotons) Forecast by Application (2025-2030)
Table 92. Global Rilpivirine Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Rilpivirine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Rilpivirine Market Size (M USD), 2019-2030
Figure 5. Global Rilpivirine Market Size (M USD) (2019-2030)
Figure 6. Global Rilpivirine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Rilpivirine Market Size by Country (M USD)
Figure 11. Rilpivirine Sales Share by Manufacturers in 2023
Figure 12. Global Rilpivirine Revenue Share by Manufacturers in 2023
Figure 13. Rilpivirine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Rilpivirine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Rilpivirine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Rilpivirine Market Share by Type
Figure 18. Sales Market Share of Rilpivirine by Type (2019-2024)
Figure 19. Sales Market Share of Rilpivirine by Type in 2023
Figure 20. Market Size Share of Rilpivirine by Type (2019-2024)
Figure 21. Market Size Market Share of Rilpivirine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Rilpivirine Market Share by Application
Figure 24. Global Rilpivirine Sales Market Share by Application (2019-2024)
Figure 25. Global Rilpivirine Sales Market Share by Application in 2023
Figure 26. Global Rilpivirine Market Share by Application (2019-2024)
Figure 27. Global Rilpivirine Market Share by Application in 2023
Figure 28. Global Rilpivirine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Rilpivirine Sales Market Share by Region (2019-2024)
Figure 30. North America Rilpivirine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Rilpivirine Sales Market Share by Country in 2023
Figure 32. U.S. Rilpivirine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Rilpivirine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Rilpivirine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Rilpivirine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Rilpivirine Sales Market Share by Country in 2023
Figure 37. Germany Rilpivirine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Rilpivirine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Rilpivirine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Rilpivirine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Rilpivirine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Rilpivirine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Rilpivirine Sales Market Share by Region in 2023
Figure 44. China Rilpivirine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Rilpivirine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Rilpivirine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Rilpivirine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Rilpivirine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Rilpivirine Sales and Growth Rate (Kilotons)
Figure 50. South America Rilpivirine Sales Market Share by Country in 2023
Figure 51. Brazil Rilpivirine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Rilpivirine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Rilpivirine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Rilpivirine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Rilpivirine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Rilpivirine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Rilpivirine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Rilpivirine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Rilpivirine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Rilpivirine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Rilpivirine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Rilpivirine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Rilpivirine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Rilpivirine Market Share Forecast by Type (2025-2030)
Figure 65. Global Rilpivirine Sales Forecast by Application (2025-2030)
Figure 66. Global Rilpivirine Market Share Forecast by Application (2025-2030)
